| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/02/1997 | EP0769942A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 05/02/1997 | EP0769938A1 A novel drug delivery system |
| 05/02/1997 | EP0769936A1 Self-emulsifying drug delivery system |
| 05/02/1997 | EP0769935A1 Pharmaceutical compositions based on chewing gum and a method for the preparation thereof |
| 05/02/1997 | EP0769932A1 Implanted device containing tumor cells for the treatment of cancer |
| 05/02/1997 | EP0590024B1 Topical composition enhancing healing of herpes lesions |
| 05/01/1997 | WO1997015655A2 New artificial tissue, method for the production and the use thereof |
| 05/01/1997 | WO1997015389A1 Preparation of peptide containing biodegradable microspheres by melt process |
| 05/01/1997 | WO1997015385A1 Water-redispersible granules including a liquid active material and a non-ionic alkoxyl-type surfactant |
| 05/01/1997 | WO1997015331A1 Methods of preserving microorganisms |
| 05/01/1997 | WO1997015330A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | WO1997015328A1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 05/01/1997 | WO1997015323A1 Infusions of neuroprotectants and thrombolytic agents |
| 05/01/1997 | WO1997015314A1 Vaginal pharmaceutical compositions containing a peroxide source |
| 05/01/1997 | WO1997015307A1 Eye drops |
| 05/01/1997 | WO1997015297A1 Compositions and methods for buccal delivery of pharmaceutical agents |
| 05/01/1997 | WO1997015296A1 Buccal delivery of glucagon-like insulinotropic peptides |
| 05/01/1997 | WO1997015295A1 Composition for transdermal delivery |
| 05/01/1997 | WO1997015294A1 Transdermal therapeutic system (tts) for administering active substances for the treatment of drug dependency or drug addiction |
| 05/01/1997 | WO1997015293A2 Method of producing multi-layer medicaments in solid form for oral or rectal administration |
| 05/01/1997 | WO1997015292A1 Method of producing medicaments in solid form |
| 05/01/1997 | WO1997015291A1 Method of producing medicaments in solid form |
| 05/01/1997 | WO1997015290A1 Method of producing medicaments in solid form |
| 05/01/1997 | WO1997015289A1 Solubilisation methods |
| 05/01/1997 | WO1997015288A2 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 05/01/1997 | WO1997015287A1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 05/01/1997 | WO1997015286A1 Method of treating wounds with a gel composition |
| 05/01/1997 | WO1997015285A1 Non-polymeric sustained release delivery system |
| 05/01/1997 | WO1997015284A1 Ophthalmic cromolyn gel preparation |
| 05/01/1997 | WO1997015269A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/01/1997 | WO1997015268A1 Moulding strip calender |
| 05/01/1997 | WO1997015243A1 Induction of immunological tolerance |
| 05/01/1997 | WO1997015195A1 Hybrid matrix implants and explants |
| 05/01/1997 | WO1997015191A1 Wet granulation formulation of a growth hormone secretagogue |
| 05/01/1997 | WO1997012601A3 Gel formulations containing growth factors |
| 05/01/1997 | CA2235832A1 Microporous pathogen-killing composition |
| 05/01/1997 | CA2235685A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | CA2235684A1 Transdermal therapeutic system (tts) for administering active substances for the treatment of drug dependency or drug addiction |
| 05/01/1997 | CA2235614A1 Eye drops |
| 05/01/1997 | CA2235602A1 Preparation of peptide containing biodegradable microspheres by melt process |
| 05/01/1997 | CA2235495A1 Methods of preserving microorganisms |
| 05/01/1997 | CA2235487A1 Solubilisation methods |
| 05/01/1997 | CA2235402A1 Compositions and methods for buccal delivery of pharmaceutical agents |
| 05/01/1997 | CA2235369A1 Buccal delivery of glucagon-like insulinotropic peptides |
| 05/01/1997 | CA2234817A1 Wet granulation formulation of a growth hormone secretagogue |
| 05/01/1997 | CA2232357A1 A process for producing solid drug forms |
| 05/01/1997 | CA2232353A1 Molding belt calender |
| 05/01/1997 | CA2205534A1 Method, compositions and kits for increasing the bioavailability of pharmaceutical agents |
| 05/01/1997 | CA2161863A1 Angiogenic material and uses thereof |
| 04/30/1997 | DE3745075C2 Therapeutic agent encapsulated in proteinoid microspheres |
| 04/30/1997 | DE19541128A1 Stabilisierte schilddrüsenhormonhaltige Arzneimittel Stabilized thyroid hormone-containing drugs |
| 04/30/1997 | DE19540132A1 Stable lyophilisate of ifosfamide containing lactose as auxiliary material |
| 04/30/1997 | DE19539574A1 Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren Compositions and methods for stabilizing biological materials by means of drying processes without freezing |
| 04/30/1997 | CN1148814A Method of mfg. and storing solutions |
| 04/30/1997 | CN1148810A Medicinal composition for treating glaucoma |
| 04/30/1997 | CN1148806A Transdermal delivery of anti-epileptic drugs |
| 04/30/1997 | CN1148805A Method for stabilizing duocarmycin derivatives |
| 04/30/1997 | CN1148804A 药物 Drug |
| 04/30/1997 | CN1148505A Activated immune globulin |
| 04/30/1997 | CN1148504A Fibrin freeze-dried drops and preparation method thereof |
| 04/30/1997 | CN1148494A Anti-cold nose drops and preparation method thereof |
| 04/30/1997 | CN1148491A Method for preparing medicinal composition in noval physical form containing heterocyclic amide derivative |
| 04/30/1997 | CN1034714C Beads having a core coated with an antifungal and a polymer |
| 04/29/1997 | US5625036 Preparation of prothrombin time reagents from recombinant human tissue factor and purified natural and synthetic phospholipids |
| 04/29/1997 | US5624975 Plastics |
| 04/29/1997 | US5624963 Process for removing bile salts from a patient and compositions therefor |
| 04/29/1997 | US5624962 For ophthalmic, dermatological and bady cavitical use |
| 04/29/1997 | US5624940 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
| 04/29/1997 | US5624898 Method for administering neurologic agents to the brain |
| 04/29/1997 | US5624687 Quick-dissolution solid preparation |
| 04/29/1997 | US5624684 Enzyme systems |
| 04/29/1997 | US5624683 Bunazosin |
| 04/29/1997 | US5624682 Pharmaceutical formulations based on a ketoprofen solution in soft capsules, and processes for their preparation |
| 04/29/1997 | US5624681 Tamper evident pharmaceutical dosage form |
| 04/29/1997 | US5624679 Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers |
| 04/29/1997 | US5624677 Controlled release of drugs delivered by sublingual or buccal administration |
| 04/29/1997 | US5624673 Cosmetic or pharmaceutical composition containing a prunella extract |
| 04/29/1997 | US5624668 Iron dextran formulations |
| 04/29/1997 | US5624597 Freeze dried sphere |
| 04/29/1997 | CA2003190C Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997014707A1 SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION |
| 04/24/1997 | WO1997014442A1 Hormone immunomodulated induction of mucosal immune responses |
| 04/24/1997 | WO1997014419A1 Transdermal delivery of alpha adrenoceptor blocking agents |
| 04/24/1997 | WO1997014415A1 Analgesic immediate and controlled release pharmaceutical composition |
| 04/24/1997 | WO1997014411A1 Percutaneous tulobuterol preparation and process for producing the same |
| 04/24/1997 | WO1997014409A1 Thrombolytic agents and methods of treatment for thrombosis |
| 04/24/1997 | WO1997014408A1 Sustained release particles |
| 04/24/1997 | WO1997014407A1 Insoluble drug delivery |
| 04/24/1997 | WO1997014400A1 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 04/24/1997 | WO1997014394A1 Liquid crystal cosmetic composition |
| 04/24/1997 | WO1997011680A3 Hormone replacement therapy method and hormone dispenser |
| 04/24/1997 | WO1997009971A3 High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems |
| 04/24/1997 | WO1997009036A3 Improved pharmaceutical ion exchange resin composition |
| 04/24/1997 | WO1997007784A3 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 04/24/1997 | WO1997006789A3 Transdermal drug delivery device having enhanced adhesion |
| 04/24/1997 | WO1996040964A3 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 04/24/1997 | WO1996040055A3 Biological agent compositions |
| 04/24/1997 | DE19642043A1 Transdermal therapeutic system for treating drug dependency |
| 04/24/1997 | DE19547691C1 Continuous prodn. of transdermal therapeutic plaster |